iTransition Development
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT04383223
- Status
- Completed
Conditions
- HIV Seropositivity
- Human Immunodeficiency Virus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- iTransition — BEHAVIORALIs a mobile website application (app), and it can be used on a range of devices (computer, tablet, smartphone) and operating systems (iOS, Android, Windows). Features of iTransition will include, but are not limited to: medication reminders, calendar tracking of appointments, direct messaging between youth and providers, and privacy password lock.
Study Details
Youth living with HIV are at high risk of falling out of care when they transition from pediatric to adult care. The investigators are proposing to develop a mobile app to help both clinical providers and patients navigate this process.
Key Dates
- Start date
- Aug 28, 2020
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2024
- Completion
- Jun 30, 2024
Study Design
- Enrollment
- 78 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: YLH Historical Control GroupParticipants in this group will have the following phases: * Screening * Single visit assessment
- Experimental: YLH iTransition Intervention GroupParticipants in this group will have the following phases: * Screening * Baseline Visit * Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3 and 9 month
- Experimental: Provider GroupParticipants in this group will have the following phases: * Screening * Baseline Visit * Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3, 9 and 15 month
- Experimental: Transition Champion GroupParticipants in this group will have the following phases: * Screening * Baseline Visit and Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3, 9 and 15 month
Primary Outcome Measure
Linkage to Adult Care [ Time Frame: 18 month post-intervention ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Grady Hospital | Atlanta | Georgia | 30303 | - |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| University of Pennsylvania Health System - HUP and Presby infectious disease clinics | Philadelphia | Pennsylvania | 19104 | - |
Find similar trials in Atlanta, GA
By condition
By specialty
Related Studies
- Harm Reduction in HIV Primary Care for PLWH Who Use DrugsRecruiting · University of Pittsburgh · Birmingham, Alabama
- Baricitinib for Reduction of HIV - CNSPHASE2 · Recruiting · William Tyor · Atlanta, Georgia
- Low Dose Naltrexone for Pain in Patients With HIVPHASE4 · Recruiting · Emory University · Atlanta, Georgia
- Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIVPHASE1 · Not Yet Recruiting · Emory University · Atlanta, Georgia